Endometrial cancer cell lines with JAK1 frameshifts have been shown to be resistant to the effects of IFNγ, including a lack of growth arrest and a failure to up regulate antigen processing and presentation [45]. This evidence concerns the gene JAK1 and endometrial cancer.